Onchocerciasis, Ocular: Clinical Trials

1 trial for Onchocerciasis, Ocular, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1

Follow Onchocerciasis, Ocular: new trials by email Literature Review of Onchocerciasis, Ocular trials Research Report on Onchocerciasis, Ocular

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Expanding Access to Preventive Chemotherapy Among Mobile and Migrant Populations
Modified Mass Administration of Medicines Strategy, Albendazole 400 mg, Praziquantel 40 mg/kg - Onchocerciasis (River Blindness), Schistosomiasis
Not applicableRecruitingUwemedimo Friday Ekpo57602026-07-012026-07-16

Narrower conditions

Elephantiasis, Filarial (1)  ·  Infections (1)  ·  Neglected Diseases (1)  ·  Onchocerciasis (1)  ·  Schistosomiasis (1)

Broader conditions

Disease Attributes (1)  ·  Eye Diseases (1)  ·  Eye Infections (1)  ·  Eye Infections, Parasitic (1)  ·  Filariasis (1)  ·  Helminthiasis (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Lymphatic Diseases (1)  ·  Lymphedema (1)  ·  Mosquito-Borne Diseases (1)  ·  Nematode Infections (1)  ·  Parasitic Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Secernentea Infections (1)

Interventions

Albendazole (1)  ·  Ivermectin (1)  ·  Mass Drug Administration (1)  ·  Mebendazole (1)  ·  Praziquantel (1)

Sponsors

Uwemedimo Friday Ekpo (1)

Countries

Nigeria (1)

Top investigators

Hammed Mogaji, PhD (1)  ·  Uwem Ekpo, PhD (1)